Projects funded by the NCN
The evaluation of therapeutic potential of β-caryophyllene in animal schizophrenia model - behavioral and molecular studies.
2022/45/N/NZ7/04059
Keywords:
schizophrenia cannabinoids endocannabinoid system CB2 receptor β-caryophyllene NMDA receptor antagonism
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ7_12: Prevention of human diseases
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 21 - announced on 2022-03-28
Amount awarded: 138 803 PLN
Project start date (Y-m-d): 2023-02-17
Project end date (Y-m-d): 2025-02-16
Project duration:: 24 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.